Advertisement
Canada markets close in 5 hours 59 minutes
  • S&P/TSX

    21,942.90
    +57.52 (+0.26%)
     
  • S&P 500

    5,096.55
    +48.13 (+0.95%)
     
  • DOW

    38,247.57
    +161.77 (+0.42%)
     
  • CAD/USD

    0.7320
    -0.0003 (-0.05%)
     
  • CRUDE OIL

    83.94
    +0.37 (+0.44%)
     
  • Bitcoin CAD

    88,140.34
    +1,462.24 (+1.69%)
     
  • CMC Crypto 200

    1,331.48
    -65.06 (-4.66%)
     
  • GOLD FUTURES

    2,351.60
    +9.10 (+0.39%)
     
  • RUSSELL 2000

    1,994.85
    +13.73 (+0.69%)
     
  • 10-Yr Bond

    4.6550
    -0.0510 (-1.08%)
     
  • NASDAQ

    15,887.77
    +276.01 (+1.77%)
     
  • VOLATILITY

    15.38
    +0.01 (+0.07%)
     
  • FTSE

    8,132.07
    +53.21 (+0.66%)
     
  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     
  • CAD/EUR

    0.6833
    +0.0012 (+0.18%)
     

Why Aurora Cannabis Stock Jumped 10% on Wednesday

edit Jars of marijuana
edit Jars of marijuana

Written by Amy Legate-Wolfe at The Motley Fool Canada

Aurora Cannabis (TSX:ACB)(NYSE:ACB) shares jumped 10% on Wednesday. The cannabis company announced it would acquire TerraFarma, the parent company of Thrive Cannabis.

What happened?

Aurora Cannabis stock jumped 10% before share came back down to earth, up about 2% as of writing. The short-lived increase to $5.08 per share came as the cannabis stock announced it would be acquiring TerraFarma. The company is the parent of Thrive Cannabis. It’s being dubbed a part of Aurora’s “premium pot strategy,” the company said in a statement.

“It’s vital that any transaction we make, now or in the future, be strategic, accretive, and centred around adding exceptional talent and brands that align with our path to profitability,” said Miguel Martin, chief executive officer of Aurora Cannabis stock. “ We see a unique opportunity to leverage [Thrive’s] expertise to deliver near and long-term benefits for both our recreational and medical markets.”

So what?

Aurora Cannabis will acquire the company for $38 million in cash and Aurora shares. However, that could come down to $20 million for Thrive in shares, cash or both should it reach revenue targets over the next two years. Now, Aurora Cannabis stock hopes this helps it reach profitability by the first half of 2023.

ADVERTISEMENT

The biggest change that Aurora Cannabis stock made is actually giving Thrive management a head role in operations, including Aurora’s recreational business. This is something that in the past, Aurora management simply has been unwilling to do. The company remains without a partnership, unlike many of its larger peers. This led to share devaluation, as the company paid for acquisitions.

Now what?

It looks like investors are still unsure of what to think. Sure, Thrive has a solid track record that could bring Aurora Cannabis stock towards profitability. But it also is a massive purchase that Aurora probably can’t afford right now. That being said, the cannabis industry remains a discount that’s hard to pass up, and opportunities won’t last forever.

Aurora Cannabis stock hasn’t purchased anything since Reliva in May 2020. Over the last few years has seen its peers merge and become massive corporations. Meanwhile, investors took the opportunity to sell their Aurora shares rather than invest, seeing perhaps a short period of time when there was a boost in price.

Only time will tell whether this proves to be the right move or not.

Shares of Aurora Cannabis stock were up 2% as of writing and 59% in the last year.

The post Why Aurora Cannabis Stock Jumped 10% on Wednesday appeared first on The Motley Fool Canada.

Should You Invest $1,000 In Aurora Cannabis Inc.?

Before you consider Aurora Cannabis Inc., we think you’ll want to hear this.

Our S&P/TSX market doubling Stock Advisor Canada team just released their top 10 starter stocks for 2022 that we believe could be a springboard for any portfolio.

Want to see if Aurora Cannabis Inc. made our list? Get started with Stock Advisor Canada today to receive all 10 of our starter stocks, a fully stocked treasure trove of industry reports, two brand-new stock recommendations every month, and much more.

See the 10 Stocks * Returns as of 1/18/22

More reading

Fool contributor Amy Legate-Wolfe has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned.

2022